{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:29:52Z","timestamp":1790195392745,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015545","name":"Seerave Foundation","doi-asserted-by":"publisher","award":["18006"],"award-info":[{"award-number":["18006"]}],"id":[{"id":"10.13039\/100015545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-CE44-0030"],"award-info":[{"award-number":["ANR-23-CE44-0030"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-23-R4HC-0006 Ener-LIGHT"],"award-info":[{"award-number":["ANR-23-R4HC-0006 Ener-LIGHT"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-22-CE14-0066"],"award-info":[{"award-number":["ANR-22-CE14-0066"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["_20195"],"award-info":[{"award-number":["_20195"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["2024ZD0519600"],"award-info":[{"award-number":["2024ZD0519600"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["2022ZD0205700"],"award-info":[{"award-number":["2022ZD0205700"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018872","name":"Labex Immuno-Oncology","doi-asserted-by":"publisher","award":["_1873"],"award-info":[{"award-number":["_1873"]}],"id":[{"id":"10.13039\/501100018872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018872","name":"Labex Immuno-Oncology","doi-asserted-by":"publisher","award":["ANR-23-RHUS-0010"],"award-info":[{"award-number":["ANR-23-RHUS-0010"]}],"id":[{"id":"10.13039\/501100018872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018872","name":"Labex Immuno-Oncology","doi-asserted-by":"publisher","award":["ANR-21-RHUS-0017"],"award-info":[{"award-number":["ANR-21-RHUS-0017"]}],"id":[{"id":"10.13039\/501100018872","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016784","name":"Equipex","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le \u00cele-de-France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101052444"],"award-info":[{"award-number":["101052444"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2021-ADG"],"award-info":[{"award-number":["ERC-2021-ADG"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014599","name":"The Mark Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101095604"],"award-info":[{"award-number":["101095604"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["861878"],"award-info":[{"award-number":["861878"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["825410"],"award-info":[{"award-number":["825410"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.xcrm.2026.102683","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:15:27Z","timestamp":1773760527000},"page":"102683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Inhibition of MAPK p38\u03b1 overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation"],"prefix":"10.1016","volume":"7","author":[{"given":"Yuhong","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misha","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ling","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Le Naour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Adriana","family":"Scuderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Doffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donal","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Felchle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Valet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Maiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Zitvogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1682-9222","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102683_bib1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: Hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102683_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.lungcan.2020.06.018","article-title":"Characteristics and outcomes of lung cancer in solid organ transplant recipients","volume":"146","author":"Chen","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.xcrm.2026.102683_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1848068","article-title":"Cancer Risks in Solid Organ Transplant Recipients: Results from a Comprehensive Analysis of 72 Cohort Studies","volume":"9","author":"Huo","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/jgh.15848","article-title":"Immunogenetics of gastrointestinal cancers: A systematic review and retrospective survey of inborn errors of immunity in humans","volume":"37","author":"Zheng","year":"2022","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102683_bib5","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S1470-2045(24)00189-X","article-title":"Cancer risk in people living with HIV and solid organ transplant recipients: a systematic review and meta-analysis","volume":"25","author":"Jin","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102683_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2023.08.002","article-title":"The show and tell of cross-presentation","volume":"159","author":"Blander","year":"2023","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41577-024-01079-5","article-title":"Striking a balance: new perspectives on homeostatic dendritic cell maturation","volume":"25","author":"Bosteels","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101410","article-title":"Dendritic cells in the tumor microenvironment: prognostic and theranostic impact","volume":"48","author":"Verneau","year":"2020","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102683_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","article-title":"Tertiary lymphoid structures in anticancer immunity","volume":"24","author":"Teillaud","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102683_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2159-8290.CD-20-0465","article-title":"A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency","volume":"11","author":"Le Naour","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102683_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2189823","article-title":"Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer","volume":"12","author":"Carbonnier","year":"2023","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2237354","article-title":"Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis","volume":"12","author":"Le Naour","year":"2023","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1126\/science.aad0779","article-title":"Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1","volume":"350","author":"Vacchelli","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102683_bib16","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1007\/s00262-021-02894-8","article-title":"Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer","volume":"70","author":"Chiang","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2026.102683_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1926074","article-title":"An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1)","volume":"10","author":"Chiang","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.21873\/invivo.13240","article-title":"Impact of Pattern Recognition Receptors on the Prognosis of Chemotherapy-treated Rectal Cancer Patients","volume":"37","author":"Chang","year":"2023","journal-title":"In Vivo"},{"key":"10.1016\/j.xcrm.2026.102683_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100732","article-title":"A genotype-phenotype screening system using conditionally immortalized immature dendritic cells","volume":"2","author":"Zhao","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2026.102683_bib20","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1158\/2159-8290.CD-22-1338","article-title":"BCL2 Inhibition Reveals a Dendritic Cell-Specific Immune Checkpoint That Controls Tumor Immunosurveillance","volume":"13","author":"Zhao","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102683_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2227510","article-title":"A Chemically Defined TLR3 Agonist with Anticancer Activity","volume":"12","author":"Le Naour","year":"2023","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151239","article-title":"Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas","volume":"132","author":"Ogino","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102683_bib23","doi-asserted-by":"crossref","first-page":"4800","DOI":"10.1038\/s41467-024-48995-7","article-title":"Author Correction: TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial","volume":"15","author":"Everson","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102683_bib24","doi-asserted-by":"crossref","first-page":"4937","DOI":"10.1158\/1078-0432.CCR-17-1866","article-title":"Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial","volume":"24","author":"Kyi","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102683_bib25","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3389\/fimmu.2019.00725","article-title":"Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial","volume":"10","author":"Saxena","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib26","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1073\/pnas.93.8.3669","article-title":"Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex \u201cre-presentation\u201d of exogenous antigen by tumor-infiltrating antigen-presenting cells","volume":"93","author":"Pulaski","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102683_bib27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/bmj.1.5794.211","article-title":"Bumetanide: potent new \u201cloop\u201d diuretic","volume":"1","author":"Asbury","year":"1972","journal-title":"Br. Med. J."},{"key":"10.1016\/j.xcrm.2026.102683_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2015.04.006","article-title":"Bumetanide-induced NKCC1 inhibition attenuates oxygen-glucose deprivation-induced decrease in proliferative activity and cell cycle progression arrest in cultured OPCs via p-38 MAPKs","volume":"1613","author":"Fu","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2026.102683_bib29","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3389\/fimmu.2018.02049","article-title":"Inhibition of NKCC1 Modulates Alveolar Fluid Clearance and Inflammation in Ischemia-Reperfusion Lung Injury via TRAF6-Mediated Pathways","volume":"9","author":"Shen","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108910","article-title":"CNS pharmacology of NKCC1 inhibitors","volume":"205","author":"Loscher","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xcrm.2026.102683_bib31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s43587-021-00122-7","article-title":"Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer's disease","volume":"1","author":"Taubes","year":"2021","journal-title":"Nat. Aging"},{"key":"10.1016\/j.xcrm.2026.102683_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00188-2017","article-title":"RV568, a narrow-spectrum kinase inhibitor with p38 MAPK-alpha and -gamma selectivity, suppresses COPD inflammation","volume":"50","author":"Charron","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.xcrm.2026.102683_bib33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/art.24266","article-title":"Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis","volume":"60","author":"Cohen","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.xcrm.2026.102683_bib34","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/art.24485","article-title":"Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies","volume":"60","author":"Damjanov","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.xcrm.2026.102683_bib35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2015.03.039","article-title":"The effect of BMS-582949, a P38 mitogen-activated protein kinase (P38 MAPK) inhibitor on arterial inflammation: a multicenter FDG-PET trial","volume":"240","author":"Emami","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.xcrm.2026.102683_bib36","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.rmed.2017.07.002","article-title":"Biological effects of p38 MAPK inhibitor losmapimod does not translate to clinical benefits in COPD","volume":"130","author":"Pascoe","year":"2017","journal-title":"Respir. Med."},{"key":"10.1016\/j.xcrm.2026.102683_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1474-4422(24)00073-5","article-title":"Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial","volume":"23","author":"Tawil","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.xcrm.2026.102683_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2019.11.006","article-title":"A randomized, double-blind, placebo-controlled phase 1b\/2 study of ralimetinib, a p38 MAPK inhibitor, plus gemcitabine and carboplatin versus gemcitabine and carboplatin for women with recurrent platinum-sensitive ovarian cancer","volume":"156","author":"Vergote","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.xcrm.2026.102683_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni.2258","article-title":"Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases","volume":"13","author":"Liu","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib40","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1900430","article-title":"A Critical Role of Formyl Peptide Receptors in Host Defense against Escherichia coli","volume":"204","author":"Zhang","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2021.110205","article-title":"MAP kinases in regulation of NOX activity stimulated through two types of formyl peptide receptors in murine bone marrow granulocytes","volume":"90","author":"Filina","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.xcrm.2026.102683_bib42","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1189\/jlb.71.1.125","article-title":"Activation of extracellular signal-related kinase by TNF-alpha controls the maturation and function of murine dendritic cells","volume":"71","author":"Yanagawa","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.xcrm.2026.102683_bib43","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.1182\/blood-2005-03-1252","article-title":"DC-SIGN ligation on dendritic cells results in ERK and PI3K activation and modulates cytokine production","volume":"107","author":"Caparros","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102683_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102105","article-title":"Protocol for colitis-associated colorectal cancer murine model induced by AOM and DSS","volume":"4","author":"Sun","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.xcrm.2026.102683_bib45","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1859064","article-title":"A major genetic accelerator of cancer diagnosis: rs867228 in FPR1","volume":"10","author":"Sztupinszki","year":"2021","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaut.2017.06.012","article-title":"Regulation of inflammation by members of the formyl-peptide receptor family","volume":"85","author":"Chen","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.xcrm.2026.102683_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1760061","article-title":"The ambiguous role of FPR1 in immunity and inflammation","volume":"9","author":"Vacchelli","year":"2020","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib48","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/srep00786","article-title":"Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes","volume":"2","author":"Liu","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102683_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122583","article-title":"Knockout of formyl peptide receptor 1 reduces osteogenesis and bone healing","volume":"344","author":"Yang","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.xcrm.2026.102683_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41586-019-1570-z","article-title":"FPR1 is the plague receptor on host immune cells","volume":"574","author":"Osei-Owusu","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102683_bib51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000353229","article-title":"CCR5 and FPR1 mediate neutrophil recruitment in endotoxin-induced lung injury","volume":"6","author":"Grommes","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.xcrm.2026.102683_bib52","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1165\/rcmb.2012-0036OC","article-title":"Genetic ablation of the fpr1 gene confers protection from smoking-induced lung emphysema in mice","volume":"47","author":"Cardini","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.xcrm.2026.102683_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125937","article-title":"FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis","volume":"5","author":"Leslie","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2026.102683_bib54","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/02713683.2024.2363473","article-title":"Formyl Peptide Receptor 1 Inhibits Reparative Angiogenesis and Aggravates Neuroretinal Dysfunction in Ischemic Retinopathy","volume":"49","author":"Zheng","year":"2024","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.xcrm.2026.102683_bib55","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.7150\/thno.57218","article-title":"Critical role of FPR1 in splenocyte migration into brain to worsen inflammation and ischemic brain injury in mice","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2026.102683_bib56","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.injury.2015.03.028","article-title":"N-Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1\/2 and P38 MAP kinase signalling pathways","volume":"46","author":"Hazeldine","year":"2015","journal-title":"Injury"},{"key":"10.1016\/j.xcrm.2026.102683_bib57","doi-asserted-by":"crossref","first-page":"L775","DOI":"10.1152\/ajplung.00466.2017","article-title":"Mitochondrial peptides cause proinflammatory responses in the alveolar epithelium via FPR-1, MAPKs, and AKT: a potential mechanism involved in acute lung injury","volume":"315","author":"Zhang","year":"2018","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.xcrm.2026.102683_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/biology9090238","article-title":"Formyl Peptide Receptor 1 Signaling in Acute Inflammation and Neural Differentiation Induced by Traumatic Brain Injury","volume":"9","author":"Fusco","year":"2020","journal-title":"Biology"},{"key":"10.1016\/j.xcrm.2026.102683_bib59","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0024-3205(03)00654-4","article-title":"The human formyl peptide receptor as model system for constitutively active G-protein-coupled receptors","volume":"73","author":"Seifert","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.xcrm.2026.102683_bib60","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00210-003-0714-7","article-title":"Functional differences between human formyl peptide receptor isoforms 26, 98, and G6","volume":"367","author":"Wenzel-Seifert","year":"2003","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.xcrm.2026.102683_bib61","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1021\/acschembio.0c00631","article-title":"Synergetic Roles of Formyl Peptide Receptor 1 Oligomerization in Ligand-Induced Signal Transduction","volume":"15","author":"Nishiguchi","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.xcrm.2026.102683_bib62","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12974-015-0473-7","article-title":"Poly(I:C) increases the expression of mPGES-1 and COX-2 in rat primary microglia","volume":"13","author":"de Oliveira","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102683_bib63","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.4049\/jimmunol.0803113","article-title":"TLR3 ligand induces NF-kappaB activation and various fates of multiple myeloma cells depending on IFN-alpha production","volume":"182","author":"Chiron","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2026.102683_bib64","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1182\/blood-2007-02-072934","article-title":"Key differences in TLR3\/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems","volume":"110","author":"Lundberg","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2026.102683_bib65","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/aur.3005","article-title":"Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies","volume":"16","author":"Fuentes","year":"2023","journal-title":"Autism Res."},{"key":"10.1016\/j.xcrm.2026.102683_bib66","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/mds.29726","article-title":"A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease","volume":"39","author":"Damier","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.xcrm.2026.102683_bib67","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10637-019-00873-6","article-title":"A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer","volume":"38","author":"Bendell","year":"2020","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.xcrm.2026.102683_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062621","article-title":"Generation of inducible immortalized dendritic cells with proper immune function in vitro and in vivo","volume":"8","author":"Richter","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102683_bib69","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1073\/pnas.89.13.6020","article-title":"Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens","volume":"89","author":"Karttunen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102683_bib70","first-page":"21","article-title":"Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen","volume":"56","author":"Lin","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102683_bib71","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102683_bib72","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/bioinformatics\/btp184","article-title":"Globally optimal stitching of tiled 3D microscopic image acquisitions","volume":"25","author":"Preibisch","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102683_bib73","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/s41592-022-01507-1","article-title":"TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines","volume":"19","author":"Ershov","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102683_bib74","article-title":"RaNA-Seq: Interactive RNA-Seq analysis from FASTQ files to functional analysis","author":"Prieto","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102683_bib75","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2026.102683_bib76","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1462431","article-title":"TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves","volume":"7","author":"Enot","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2026.102683_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102683_bib78","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41467-019-09415-3","article-title":"Crizotinib-induced immunogenic cell death in non-small cell lung cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102683_bib79","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/gast.2003.50094","article-title":"Pathology of mouse models of intestinal cancer: consensus report and recommendations","volume":"124","author":"Boivin","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2026.102683_bib80","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/0192623313505156","article-title":"Rodent intestinal epithelial carcinogenesis: pathology and preclinical models","volume":"42","author":"Ward","year":"2014","journal-title":"Toxicol. Pathol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T16:22:19Z","timestamp":1783095739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912600100X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S266637912600100X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102683","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of MAPK p38\u03b1 overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102683","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102683"}}